sodium chloride 0.9% solution

DRUG3 trials

Sponsors

Nektar Therapeutics, Novo Nordisk A/S, Tanta University

Conditions

Atopic DermatitisDelivery SystemsDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Laparoscopic HysterectomyLidocaineOptic Nerve Sheath Diameter

Phase 1

Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations

CompletedNCT01680328

Novo Nordisk A/SDelivery Systems, Diabetes, Diabetes Mellitus, Type 1 +1

Start: 2012-08-31End: 2012-10-31Updated: 2017-03-03

Phase 2

A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rezpegaldesleukin in the Treatment of Adult Patients with Moderate-to-Severe Atopic Dermatitis (REZOLVE-AD).

Active, not recruitingCTIS2023-507456-69-00

Nektar TherapeuticsAtopic Dermatitis

Start: 2024-04-25Target: 366Updated: 2025-10-30

Unknown Phase

Lidocaine Infusion on Optic Nerve Sheath Diameter in Laparoscopic Hysterectomy in Trendelenburg Position

CompletedNCT05690087

Tanta UniversityLaparoscopic Hysterectomy, Lidocaine, Optic Nerve Sheath Diameter +1

Start: 2023-02-01End: 2024-01-01Updated: 2024-01-03